The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment, tolerability and outcomes of enfortumab vedotin plus pembrolizumab in advanced urothelial carcinoma: An analysis of the Austrian enfortumab registry.
 
Dora Niedersuess -Beke
Honoraria - Astellas Oncology
Speakers' Bureau - BMS GmbH & Co. KG; MSD Oncology
Research Funding - Astellas Oncology (Inst)
Travel, Accommodations, Expenses - Merck KGaA
 
Renate Pichler
Consulting or Advisory Role - Astellas Oncology
Research Funding - Astellas Oncology
 
Johanna Krauter
No Relationships to Disclose
 
Ferdinand Luger
No Relationships to Disclose
 
Dominik Vais
No Relationships to Disclose
 
Roman Taedcke
No Relationships to Disclose
 
Stefan Aufderklamm
No Relationships to Disclose
 
Franz Stoiber
No Relationships to Disclose
 
Shahrokh Shariat
Consulting or Advisory Role - Astellas Oncology
Speakers' Bureau - Astellas Oncology; MSD
 
Susanne Schnabel
No Relationships to Disclose
 
Simon Gampenrieder
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD; Novartis; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Lilly; MSD; Novartis; Pfizer; Seagen; Stemline Therapeutics
Research Funding - AstraZeneca (Inst); Caris Life Sciences (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly (Inst); Gilead Sciences (Inst); Janssen (Inst); Roche (Inst)
 
Josef Muehlmann
Consulting or Advisory Role - Astellas Oncology
 
Jasmin Spiegelberg
No Relationships to Disclose
 
Thomas Bauernhofer
Consulting or Advisory Role - Astellas Oncology
Speakers' Bureau - Astellas Oncology
 
Andreas Banner
No Relationships to Disclose
 
Sabine Weibrecht
No Relationships to Disclose
 
Clemens Wiesinger
No Relationships to Disclose
 
Jan Miechowiecki
No Relationships to Disclose
 
Daniel Heintel
No Relationships to Disclose
 
Karl Mayrhofer
No Relationships to Disclose